XML 31 R25.htm IDEA: XBRL DOCUMENT v3.25.1
Equity Method Investment (Tables)
 3 Months Ended
Mar. 31, 2025
Equity Method Investments and Joint Ventures [Abstract]  
Schedule Of Equity Method Investments Our loss of $4.5 million for our investment in Gannet BioChem for the three months ended March 31, 2025 is as follows (in thousands):

 

 

 

 

Claim on net assets of Gannet BioChem - beginning of period

 

$

12,218

 

Claim on net assets of Gannet BioChem - end of period

 

 

7,757

 

Change in claim on net assets of Gannet BioChem

 

$

(4,461

)